Capricor Therapeutics
CAPR
#7991
Rank
$0.29 B
Marketcap
$6.36
Share price
-4.36%
Change (1 day)
-57.23%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -$81.99 Million USD

According to Capricor Therapeutics 's latest financial reports the company's current earnings are $11.13 Million USD. In 2024 the company made an earning of -$40.47 Million USD a decrease over its 2023 earnings that were of -$22.29 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$81.99 Million102.61%
2024 -$40.47 Million81.57%
2023 -$22.29 Million-23.2%
2022 -$29.02 Million44.93%
2021 -$20.03 Million46.61%
2020 -$13.66 Million78.71%
2019 -$7.65 Million-49.7%
2018 -$15.2 Million-724.78%
2017 $2.43 M-112.93%
2016 -$18.81 Million46.27%
2015 -$12.86 Million106.82%
2014 -$6.22 Million-48.41%
2013 -$12.06 Million977.23%
2012 -$1.12 Million-77.11%
2011 -$4.89 Million-22.35%
2010 -$6.3 Million-20.17%
2009 -$7.89 Million-41.17%
2008 -$13.4 Million41.05%
2007 -$9.51 Million1098.87%
2006 -$0.8 Million4101.55%
2005 -$0.02 Million-0.97%
2004 -$0.02 Million17.87%
2003 -$0.02 Million3.66%
2002 -$0.02 Million-30.11%
2001 -$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-$0.76 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$17.3 Million-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.58 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.26 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$9.49 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA